Tower Research Capital (TRC)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $98.1K | Sell |
|
|||||
|
2025
Q2 | $9.89M | Buy |
|
|||||
|
2025
Q1 | $605K | Sell |
|
|||||
|
2024
Q4 | $1.09M | Buy |
|
|||||
|
2024
Q3 | $1.18M | Sell |
|
|||||
|
2024
Q2 | $2.43M | Buy |
|
|||||
|
2024
Q1 | $1.15M | Buy |
|
|||||
|
2023
Q4 | $409K | Buy |
|
|||||
|
2023
Q3 | $187K | Sell |
|
|||||
|
2023
Q2 | $294K | Buy |
|
|||||
|
2023
Q1 | $32K | Buy |
|
|||||
|
2022
Q4 | $10K | Sell |
|
|||||
|
2022
Q3 | $788K | Buy |
|
|||||
|
2022
Q2 | $453K | Buy |
|
|||||
|
2022
Q1 | $398K | Sell |
|
|||||
|
2021
Q4 | $1.04M | Buy |
|
|||||
|
2021
Q3 | $3K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $380K | Buy |
|
|||||
|
2020
Q4 | $267K | Sell |
|
|||||
|
2020
Q3 | $291K | Buy |
|
|||||
|
2020
Q2 | $14K | Sell |
|
|||||
|
2020
Q1 | $14K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $18K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $135K | Buy |
|
|||||
|
2018
Q4 | $1K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $17K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $69K | Sell |
|
|||||
|
2017
Q2 | $96K | Sell |
|
|||||
|
2017
Q1 | $105K | Buy |
|
|||||
|
2016
Q4 | $41K | Buy |
|
|||||
|
2016
Q3 | $10K | Sell |
|
|||||
|
2016
Q2 | $167K | Buy |
|
|||||
|
2016
Q1 | $5K | Hold |
|
|||||
|
2015
Q4 | $6K | Sell |
|
|||||
|
2015
Q3 | $53K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $108K | Buy |
|
|||||
|
2014
Q4 | $11K | Buy |
|
|||||
|
2014
Q3 | $5K | Buy |
|
|||||
|
2014
Q2 | $1K | Sell |
|
|||||
|
2014
Q1 | $61K | Sell |
|
|||||
|
2013
Q4 | $163K | Buy |
|
|||||
|
2013
Q3 | $61K | Buy |
|
|||||
|
2013
Q2 | $23K | Buy |
|